These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 874953)

  • 41. Intramolecular hydrogen bond-controlled prolyl amide isomerization in glucosyl 3'(S)-hydroxy-5'-hydroxymethylproline hybrids: influence of a C-5'-hydroxymethyl substituent on the thermodynamics and kinetics of prolyl amide cis/trans isomerization.
    Zhang K; Teklebrhan RB; Schreckenbach G; Wetmore S; Schweizer F
    J Org Chem; 2009 May; 74(10):3735-43. PubMed ID: 19354261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antitumor activity of a novel water soluble mitomycin analog; 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C.
    Kono M; Saitoh Y; Kasai M; Sato A; Shirahata K; Morimoto M; Ashizawa T
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1128-30. PubMed ID: 2766417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2.
    Degel B; Staib P; Rohrer S; Scheiber J; Martina E; Büchold C; Baumann K; Morschhäuser J; Schirmeister T
    ChemMedChem; 2008 Feb; 3(2):302-15. PubMed ID: 18038380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autocatalytic quinone methide formation from mitomycin c.
    Peterson DM; Fisher J
    Biochemistry; 1986 Jul; 25(14):4077-84. PubMed ID: 3091069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA sequence specificity of mitomycin cross-linking.
    Teng SP; Woodson SA; Crothers DM
    Biochemistry; 1989 May; 28(9):3901-7. PubMed ID: 2751999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The mitomycin antibiotics.
    Franck RW
    Fortschr Chem Org Naturst; 1979; 38():1-45. PubMed ID: 397160
    [No Abstract]   [Full Text] [Related]  

  • 49. Preparation and antitumor activity of additional mitomycin A analogues.
    Sami SM; Remers WA; Bradner WT
    J Med Chem; 1989 Mar; 32(3):703-8. PubMed ID: 2918519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential anti-tumour 2,5-bis (1-aziridinyl)-1,4-benzoquinones: relationship between cytotoxicity against DNA-repair deficient E. coli, inactivation of bacteriophage M13mp19, and in vitro and in vivo anti-tumour activity.
    Lusthof KJ; Groothuis-Pielage IL; Decuyper J; de Mol NJ; Janssen LH; Verboom W; Reinhoudt DN
    Anticancer Drug Des; 1988 Dec; 3(3):147-55. PubMed ID: 3061386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An antagonistic effect between aziridine and diaziridine on their cytotoxic activities against L-1210 mouse leukemia cells.
    Takase S; Watanabe M; Shiratori O; Hata Y
    Biochem Biophys Res Commun; 1982 Jan; 104(2):746-9. PubMed ID: 7073712
    [No Abstract]   [Full Text] [Related]  

  • 52. Nucleotide derivatives of 2,7-diaminomitosene.
    Iyengar BS; Dorr RT; Remers WA; Kowal CD
    J Med Chem; 1988 Aug; 31(8):1579-85. PubMed ID: 3397995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alkylating esters. X. The reaction of some aziridine alkylating agents with methionine and S-methyl cysteine.
    Jones AR; Capps PA
    Chem Biol Interact; 1977 Feb; 16(2):181-9. PubMed ID: 849623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and structural characterization of trivalent amino acid derived chiral phosphorus compounds.
    Hersh WH; Xu P; Simpson CK; Grob J; Bickford B; Hamdani MS; Wood T; Rheingold AL
    J Org Chem; 2004 Mar; 69(6):2153-63. PubMed ID: 15058965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA cross-linking by intermediates in the mitomycin activation cascade.
    Cera C; Egbertson M; Teng SP; Crothers DM; Danishefsky SJ
    Biochemistry; 1989 Jun; 28(13):5665-9. PubMed ID: 2775730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitomycin synthetic studies: stereocontrolled and convergent synthesis of a fully elaborated aziridinomitosane.
    Coleman RS; Felpin FX; Chen W
    J Org Chem; 2004 Oct; 69(21):7309-16. PubMed ID: 15471485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reductive activation of mitomycin C.
    Hoey BM; Butler J; Swallow AJ
    Biochemistry; 1988 Apr; 27(7):2608-14. PubMed ID: 3132971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformations of complexes between mitomycins and decanucleotides. 3. Sequence specificity, binding at C-10, and mitomycin analogues.
    Remers WA; Rao SN; Wunz TP; Kollman PA
    J Med Chem; 1988 Aug; 31(8):1612-20. PubMed ID: 3397999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on the mode of action of the mitomycin antibiotics. Reversible conversion of mitomycin C into sodium 7-aminomitosane-9a-sulfonate.
    Hornemann U; Ho YK; Mackey JK; Srivastava SC
    J Am Chem Soc; 1976 Oct; 98(22):7069-74. PubMed ID: 965666
    [No Abstract]   [Full Text] [Related]  

  • 60. The molecular structure of 7-demethoxy-7-p-bromoanilino mitomycin B.
    Yahashi R; Matsubara I
    J Antibiot (Tokyo); 1976 Jan; 29(1):104-6. PubMed ID: 931788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.